Literature DB >> 8584498

Improved cellular delivery of antisense oligonucleotides using transferrin receptor antibody-oligonucleotide conjugates.

I Walker1, W J Irwin, S Akhtar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8584498     DOI： 10.1023/a:1016260110049

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  8 in total

Review 1.  DNA antisense strategies in the study of receptors for vasoactive peptides, and of growth and wound-healing factors.

Authors:  P D'Orléans-Juste; M G Sirois; E R Edelman; D Regoli; L H Pheng; G Bkaily; C J Lindsey
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

2.  Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.

Authors:  R Chakraborty; D Dasgupta; S Adhya; M K Basu
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

3.  Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus.

Authors:  E G Marcusson; B Bhat; M Manoharan; C F Bennett; N M Dean
Journal:  Nucleic Acids Res       Date:  1998-04-15       Impact factor: 16.971

4.  A Platform for Site-Specific DNA-Antibody Bioconjugation by Using Benzoylacrylic-Labelled Oligonucleotides.

Authors:  Juraj Konč; Libby Brown; Daniel R Whiten; Yukun Zuo; Peter Ravn; David Klenerman; Gonçalo J L Bernardes
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-03       Impact factor: 16.823

Review 5.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

6.  Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.

Authors:  Noriko Satake; Connie Duong; Sakiko Yoshida; Michael Oestergaard; Cathy Chen; Rachael Peralta; Shuling Guo; Punit P Seth; Yueju Li; Laurel Beckett; Jong Chung; Jan Nolta; Nitin Nitin; Joseph M Tuscano
Journal:  Mol Med       Date:  2016-07-22       Impact factor: 6.354

Review 7.  Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy.

Authors:  Huiyuan Wang; Cheol Moon; Meong Cheol Shin; Yaping Wang; Huining He; Victor C Yang; Yongzhuo Huang
Journal:  Nanotheranostics       Date:  2017-03-03

8.  Non-specific interactions of antibody-oligonucleotide conjugates with living cells.

Authors:  Victor Lehot; Isabelle Kuhn; Marc Nothisen; Stéphane Erb; Sergii Kolodych; Sarah Cianférani; Guilhem Chaubet; Alain Wagner
Journal:  Sci Rep       Date:  2021-03-15       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.